Filing Flows › Vir Biotechnology (VIR) › Stock forecast & fair value
Vir Biotechnology (VIR) stock forecast and price target
Vir Biotechnology (VIR) trades at $12.21. 8 analysts' median price target is $20.50 (+68%), from $15.00 to $30.00.
Vir Biotechnology's latest quarter
Vir Biotechnology, Q2 2026: revenue $239M (197× year over year), operating margin 30.7%, net earnings $80.1M, operating cash flow $123M. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for VIR stock?
The median of 8 analysts' 12-month targets is $20.50, +68% from $12.21; the range is $15.00 to $30.00. The average rating is strong buy.
Does Vir Biotechnology usually beat earnings estimates?
It beat the consensus EPS estimate in 40% of the quarters on record.
Is VIR stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.